Pictet Asset Management (UK)’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $17.5M | Sell |
71,009
-147
| -0.2% | -$30.9K | 0.02% | 554 |
|
|
2021
Q1 | $13.8M | Sell |
71,156
-4,600
| -6% | -$922K | 0.02% | 582 |
|
|
2020
Q4 | $16.1M | Buy |
75,756
+3,300
| +5% | +$658K | 0.02% | 522 |
|
|
2020
Q3 | $12.4M | Sell |
72,456
-2,000
| -3% | -$369K | 0.02% | 513 |
|
|
2020
Q2 | $14.3M | Buy |
74,456
+1,350
| +2% | +$221K | 0.02% | 451 |
|
|
2020
Q1 | $10.8M | Buy |
73,106
+2,400
| +3% | +$382K | 0.02% | 468 |
|
|
2019
Q4 | $11M | Sell |
70,706
-500
| -0.7% | -$72.1K | 0.02% | 561 |
|
|
2019
Q3 | $9.62M | Sell |
71,206
-3,800
| -5% | -$498K | 0.02% | 540 |
|
|
2019
Q2 | $9.15M | Sell |
75,006
-500
| -0.7% | -$55.4K | 0.02% | 540 |
|
|
2019
Q1 | $7.85M | Buy |
75,506
+2,700
| +4% | +$279K | 0.02% | 590 |
|
|
2018
Q4 | $8.29K | Sell |
72,806
-4,500
| -6% | -$482K | 0.02% | 530 |
|
|
2018
Q3 | $8.92M | Sell |
77,306
-5,300
| -6% | -$581K | 0.02% | 593 |
|
|
2018
Q2 | $8.56M | Buy |
82,606
+5,300
| +7% | +$536K | 0.02% | 546 |
|
|
2018
Q1 | $7.61M | Sell |
77,306
-11,500
| -13% | -$1.09M | 0.02% | 563 |
|
|
2017
Q4 | $7.52M | Sell |
88,806
-1,294
| -1% | -$107K | 0.02% | 573 |
|
|
2017
Q3 | $6.93M | Buy |
90,100
+21,000
| +30% | +$1.61M | 0.02% | 564 |
|
|
2017
Q2 | $4.91M | Sell |
69,100
-500
| -0.7% | -$35.8K | 0.02% | 623 |
|
|
2017
Q1 | $5.01M | Buy |
69,600
+4,349
| +7% | +$301K | 0.02% | 612 |
|
|
2016
Q4 | $4.05M | Sell |
65,251
-700
| -1% | -$42.9K | 0.02% | 623 |
|
|
2016
Q3 | $4.27M | Sell |
65,951
-34,600
| -34% | -$2.3M | 0.02% | 612 |
|
|
2016
Q2 | $5.94M | Buy |
100,551
+20,900
| +26% | +$1.23M | 0.02% | 540 |
|
|
2016
Q1 | $4.53M | Hold |
79,651
| – | – | 0.02% | 553 |
|
|
2015
Q4 | $4.28M | Sell |
79,651
-900
| -1% | -$50.7K | 0.02% | 588 |
|
|
2015
Q3 | $4.11M | Buy |
80,551
+11,200
| +16% | +$603K | 0.02% | 597 |
|
|
2015
Q2 | $4.02M | Sell |
69,351
-700
| -1% | -$44.2K | 0.02% | 635 |
|
|
2015
Q1 | $4.48M | Sell |
70,051
-42,635
| -38% | -$2.77M | 0.02% | 606 |
|
|
2014
Q4 | $6.32M | Buy |
112,686
+40,835
| +57% | +$2.13M | 0.03% | 518 |
|
|
2014
Q3 | $3.54M | Sell |
71,851
-3,500
| -5% | -$178K | 0.02% | 631 |
|
|
2014
Q2 | $3.81M | Buy |
75,351
+2,800
| +4% | +$139K | 0.02% | 616 |
|
|
2014
Q1 | $3.24M | Sell |
72,551
-2,400
| -3% | -$108K | 0.02% | 643 |
|
|
2013
Q4 | $3.53M | Hold |
74,951
| – | – | 0.02% | 611 |
|
|
2013
Q3 | $3.96M | Buy |
74,951
+18,051
| +32% | +$876K | 0.02% | 579 |
|
|
2013
Q2 | $2.57M | Buy |
+56,900
| New | +$2.7M | 0.01% | 654 |
|
Other funds holding RMD
Pictet Asset Management (UK)'s RMD Position: Q2 2021 in Review
Pictet Asset Management (UK) reduced its ResMed (RMD) stake by 0.21% in Q2 2021, selling an estimated $30.9K and leaving 71,009 shares worth $17.5M. The position accounts for 0.02% of the portfolio, ranked #554.
Pictet Asset Management (UK) first reported a position in RMD in Q2 2013 and has held it in 33 quarters since. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.
- Pictet Asset Management (UK) held 71,009 shares of ResMed worth $17.5M as of Q2 2021.
- Pictet Asset Management (UK) sold 147 ResMed shares in Q2 2021, an estimated $30.9K.
- ResMed made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #554 holding.
- Pictet Asset Management (UK) first reported a position in ResMed in Q2 2013 and has held it in 33 quarters since.
- 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.